Objective:To compare the safety and efficacy of 3D-printed porous bioceramic artificial bone and artificial bone substitutes in the treatment of limb bone defects.Methods:A total of 220 patients with post-traumatic limb bone defects admitted to Xijing Hospital Affiliated to Air Force Medical University of the Chinese People's Liberation Army (34 cases), the Third Hospital of Hebei Medical University (60 cases), Xi'an Honghui Hospital (28 cases), the Third Hospital of Southern Medical University (18 cases), Changsha Third Hospital (28 cases), Foshan Traditional Chinese Medicine Hospital (16 cases), Foshan Fuxing Chancheng Hospital (12 cases), and Henan Provincial Orthopaedic Hospital (24 cases) from May 2022 to October 2023 were included as research subjects. According to the manufacturing method of the bone graft material, the subjects were randomly divided into the 3D printed porous bioceramic artificial bone group (3D printing group) and the artificial bone substitute group (non-3D printing group) at a ratio of 1:1 by the envelope method. Adverse events that might be related to the surgery were selected through correlation evaluation and classified as abnormal laboratory indicators, systemic or other site symptoms and abnormalities, and local symptoms and abnormalities of the affected limb. The safety of the two groups was compared. The bone graft fusion rate, bone defect repair and healing rate, and short form 12 (SF-12) score of the two groups were calculated to evaluate the postoperative recovery.Results:Thirty-two cases were excluded (4 cases refused to use their data after reconsideration, 7 cases were not used after preoperative assessment, and 21 cases exceeded the standard for body mass index and laboratory indicators upon re-examination). A total of 188 cases were randomly divided into the 3D printing group and the non-3D printing group according to the random method, with 94 cases in each group. Among them, 11 cases in the 3D printing group and 9 cases in the non-3D printing group dropped out due to loss to follow-up. Finally, 168 cases completed the follow-up, including 83 cases in the 3D printing group and 85 cases in the non-3D printing group. In the 3D printing group, there were 53 males and 30 females, with an average age of 47.9±12.7 years; in the non-3D printing group, there were 53 males and 32 females, with an average age of 48.6±12.9 years. A total of 51 cases in the two groups experienced adverse events related to the surgery, including 13 cases of abnormal laboratory indicators (5 cases in the 3D printing group and 8 cases in the non-3D printing group), 15 cases of systemic or other site symptoms and abnormalities (9 cases in the 3D printing group and 6 cases in the non-3D printing group), and 23 cases of local symptoms and abnormalities of the affected limb (13 cases in the 3D printing group and 10 cases in the non-3D printing group). There was no statistically significant difference in the incidence of adverse events between the two groups ( P>0.05). The bone graft fusion rates of the 3D printing group and the non-3D printing group at 6 months after surgery were 99%(82/83) and 99%(84/85), respectively, and the bone defect repair and healing rates were 89%(74/83) and 89%(76/85), respectively. At the time of 12 months after surgery, the bone graft fusion rates were 99%(82/83) and 99%(84/85), respectively, and the bone defect repair and healing rates were 94%(78/83) and 92%(78/85), respectively. There was no statistically significant difference in the bone graft fusion rate and bone defect repair and healing rate between the two groups ( P>0.05). The SF-12 scores during the screening period were 27.82±2.96 points and 27.22±4.23 points in the 3D printing group and the non-3D printing group, respectively, and at 3 months after surgery were 28.08±3.13 points and 27.64±3.16 points, at 6 months after surgery were 29.42±3.10 points and 28.55±3.45 points, and at 12 months after surgery were 29.78±2.80 points and 29.58±2.94 points, respectively. There was no statistically significant difference between the groups ( P>0.05). Both groups of surgeries were successfully completed without any serious surgical or bone graft-related complications. Conclusion:The safety and efficacy of 3D-printed porous bioceramic artificial bone in the treatment of limb bone defects are not significantly different from those of currently clinically applied artificial bone substitutes.

Objective:To evaluate the therapeutic role of balanced matching concept in the surgical release of moderate and severe elbow stiffness after trauma.Methods:A retrospective study was conducted to analyze the clinical data of 20 patients who had been treated by surgical release from June 2022 to January 2024 for elbow stiffness after moderate and severe trauma at Department of Orthopedic Trauma, The First Hospital Affiliated to Air Force Medical University of PLA using the balanced matching concept (combination of elbow soft tissue balance and bone matching). There were 15 males and 5 females, with an age of (33.0±8.9) years. Six left sides and 14 right sides were affected. The elbow stiffness was severe in 13 cases and moderate in 7 cases. Six patients had mainly bony stiffness, 4 patients mainly soft stiffness, and 10 patients mixed stiffness. The elbow flexion and extension, Mayo elbow performance score (MEPS) and disabilities of the arm, shoulder, and hand (DASH) score were recorded and compared before release and at the last follow-up. The recurrence of ectopic ossification, infection, iatrogenic fracture and other complications of the elbow joint of the affected limb were recorded.Results:All the 20 patients were followed up for (16.6±3.5) months. At the last follow-up, the elbow flexion and extension (121.8°±8.9° and 14.8°±8.2°) were significantly greater than those before operation (73.5°±25.7° and 47.3°±19.2°), and the MEPS and DASH scores [ (90.0±5.6) points, (5.6±3.0) points] were significantly better than those before operation [(53.0±12.8) points, (62.1±14.0) points] ( P<0.05). Iatrogenic fracture of the ulna occurred in 1 patient, and pinky numbness occurred in 1 patient after surgery. None of the patients had recurrence of ectopic ossification or wound infection. Conclusion:In the surgical release of moderate and severe elbow stiffness after trauma, the concept of balanced matching plays a positive role by facilitating the functional restoration of the elbow and reducing the incidence of complications.

Objective:To compare the safety and efficacy of 3D-printed porous bioceramic artificial bone and artificial bone substitutes in the treatment of limb bone defects.Methods:A total of 220 patients with post-traumatic limb bone defects admitted to Xijing Hospital Affiliated to Air Force Medical University of the Chinese People's Liberation Army (34 cases), the Third Hospital of Hebei Medical University (60 cases), Xi'an Honghui Hospital (28 cases), the Third Hospital of Southern Medical University (18 cases), Changsha Third Hospital (28 cases), Foshan Traditional Chinese Medicine Hospital (16 cases), Foshan Fuxing Chancheng Hospital (12 cases), and Henan Provincial Orthopaedic Hospital (24 cases) from May 2022 to October 2023 were included as research subjects. According to the manufacturing method of the bone graft material, the subjects were randomly divided into the 3D printed porous bioceramic artificial bone group (3D printing group) and the artificial bone substitute group (non-3D printing group) at a ratio of 1:1 by the envelope method. Adverse events that might be related to the surgery were selected through correlation evaluation and classified as abnormal laboratory indicators, systemic or other site symptoms and abnormalities, and local symptoms and abnormalities of the affected limb. The safety of the two groups was compared. The bone graft fusion rate, bone defect repair and healing rate, and short form 12 (SF-12) score of the two groups were calculated to evaluate the postoperative recovery.Results:Thirty-two cases were excluded (4 cases refused to use their data after reconsideration, 7 cases were not used after preoperative assessment, and 21 cases exceeded the standard for body mass index and laboratory indicators upon re-examination). A total of 188 cases were randomly divided into the 3D printing group and the non-3D printing group according to the random method, with 94 cases in each group. Among them, 11 cases in the 3D printing group and 9 cases in the non-3D printing group dropped out due to loss to follow-up. Finally, 168 cases completed the follow-up, including 83 cases in the 3D printing group and 85 cases in the non-3D printing group. In the 3D printing group, there were 53 males and 30 females, with an average age of 47.9±12.7 years; in the non-3D printing group, there were 53 males and 32 females, with an average age of 48.6±12.9 years. A total of 51 cases in the two groups experienced adverse events related to the surgery, including 13 cases of abnormal laboratory indicators (5 cases in the 3D printing group and 8 cases in the non-3D printing group), 15 cases of systemic or other site symptoms and abnormalities (9 cases in the 3D printing group and 6 cases in the non-3D printing group), and 23 cases of local symptoms and abnormalities of the affected limb (13 cases in the 3D printing group and 10 cases in the non-3D printing group). There was no statistically significant difference in the incidence of adverse events between the two groups ( P>0.05). The bone graft fusion rates of the 3D printing group and the non-3D printing group at 6 months after surgery were 99%(82/83) and 99%(84/85), respectively, and the bone defect repair and healing rates were 89%(74/83) and 89%(76/85), respectively. At the time of 12 months after surgery, the bone graft fusion rates were 99%(82/83) and 99%(84/85), respectively, and the bone defect repair and healing rates were 94%(78/83) and 92%(78/85), respectively. There was no statistically significant difference in the bone graft fusion rate and bone defect repair and healing rate between the two groups ( P>0.05). The SF-12 scores during the screening period were 27.82±2.96 points and 27.22±4.23 points in the 3D printing group and the non-3D printing group, respectively, and at 3 months after surgery were 28.08±3.13 points and 27.64±3.16 points, at 6 months after surgery were 29.42±3.10 points and 28.55±3.45 points, and at 12 months after surgery were 29.78±2.80 points and 29.58±2.94 points, respectively. There was no statistically significant difference between the groups ( P>0.05). Both groups of surgeries were successfully completed without any serious surgical or bone graft-related complications. Conclusion:The safety and efficacy of 3D-printed porous bioceramic artificial bone in the treatment of limb bone defects are not significantly different from those of currently clinically applied artificial bone substitutes.

Objective:To evaluate the therapeutic role of balanced matching concept in the surgical release of moderate and severe elbow stiffness after trauma.Methods:A retrospective study was conducted to analyze the clinical data of 20 patients who had been treated by surgical release from June 2022 to January 2024 for elbow stiffness after moderate and severe trauma at Department of Orthopedic Trauma, The First Hospital Affiliated to Air Force Medical University of PLA using the balanced matching concept (combination of elbow soft tissue balance and bone matching). There were 15 males and 5 females, with an age of (33.0±8.9) years. Six left sides and 14 right sides were affected. The elbow stiffness was severe in 13 cases and moderate in 7 cases. Six patients had mainly bony stiffness, 4 patients mainly soft stiffness, and 10 patients mixed stiffness. The elbow flexion and extension, Mayo elbow performance score (MEPS) and disabilities of the arm, shoulder, and hand (DASH) score were recorded and compared before release and at the last follow-up. The recurrence of ectopic ossification, infection, iatrogenic fracture and other complications of the elbow joint of the affected limb were recorded.Results:All the 20 patients were followed up for (16.6±3.5) months. At the last follow-up, the elbow flexion and extension (121.8°±8.9° and 14.8°±8.2°) were significantly greater than those before operation (73.5°±25.7° and 47.3°±19.2°), and the MEPS and DASH scores [ (90.0±5.6) points, (5.6±3.0) points] were significantly better than those before operation [(53.0±12.8) points, (62.1±14.0) points] ( P<0.05). Iatrogenic fracture of the ulna occurred in 1 patient, and pinky numbness occurred in 1 patient after surgery. None of the patients had recurrence of ectopic ossification or wound infection. Conclusion:In the surgical release of moderate and severe elbow stiffness after trauma, the concept of balanced matching plays a positive role by facilitating the functional restoration of the elbow and reducing the incidence of complications.

OBJECTIVE To explore the therapeutic effect and safety of tolvaptan in the treatment of heart failure with preserved ejection fraction （HFpEF） complicated with hyponatremia. METHODS Overall 106 patients with HFpEF complicated with hyponatremia were collected from the Department of Cardiology in the First Affiliated Hospital of Nanyang Medical College from January 1， 2020 to June 1， 2023. According to the random number table， the patients were divided into conventional treatment group （n＝53） and tolvaptan group （n＝53）. The conventional treatment group was given conventional treatment. Tolvaptan group additionally received Tolvaptan tablets 15 mg on the basis of conventional treatment group， increasing to 30 mg after 24 h， and then adjusting the dosage according to the levels of serum sodium； the maximum dose should not exceed 60 mg/d， and the medication should be stopped when the serum sodium level was≥150 mmol/L. Both groups of patients were treated for 6 months. The levels and changes of cardiac function indexes [left ventricular ejection fraction （LVEF）， left ventricular end systolic diameter （LVESD）， left ventricular end diastolic diameter （LVEDD）， N-terminal pro-brain natriuretic peptide （NT-proBNP）]， 24 h urine output， serum sodium， blood creatinine and urea nitrogen were compared between 2 groups before and after treatment. The occurrence of adverse drug reaction （ADR） was recorded. RESULTS Before treatment， there was no statistically significant difference in those indexes between 2 groups （P＞0.05）. After treatment， the levels of LVEF， 24 h urine output and serum sodium in 2 groups were significantly higher than before treatment， and the tolvaptan group was significantly higher than the conventional treatment group； the levels of LVESD， LVEDD and NT-proBNP were significantly lower than before treatment， and the tolvaptan group was significantly lower than the conventional treatment group （P＜0.05 or P＜0.01）. The changes in cardiac function indexes， 24 h urine output and serum sodium levels in the atorvastatin group were more significant than the conventional treatment group （P＜0.05）. There was no statistically significant difference in the levels and changes of blood creatinine and urea nitrogen before and after treatment， as well as the incidence of nausea and vomiting， dizziness， hypernatremia and frequent urination between 2 groups （P＞0.05）. CONCLUSIONS Tolvaptan can improve cardiac function and increase the blood sodium levels in patients with HFpEF complicated with hyponatremia， without affecting their renal function or increasing the risk of ADR.

Objective:To provide an effective protection method for reducing the ankle injury during airborne force landing by investigating the protective effect of a protective ankle brace (PAB).Methods:Airborne soldiers were selected as subjects and they were asked to jump from 1.5 m and 2 m high training platform with and without PAB protection. They maintained a standard bending and knee-bending posture as they touched the buffer surface of the training ground. Each subject completed 4 simulated landing trials: from 1.5 m with PAB (1.5 m PAB group), from 2 m with PAB (2 m PAB group), from 1.5 m without PAB (1.5 m control group), and from 2 m without PAB (2 m control group). The muscle electrical signals of bilateral tibialis anterior, peroneal longus and brevis and gastrocnemius were recorded by surface electromyography, and the percentage of maximal voluntary electrical activation (MVE%) was calculated and analyzed.Results:Sixty-one subjects were included. At the same height with different ankle protection status, the MVE% values of bilateral tibialis anterior and gastrocnemius in the 1.5 m PAB group were lower than those in the 1.5 m control group, and the differences were significant ( t=2.45, 2.74, 2.35, P=0.017, 0.008, 0.022). The MVE% values of bilateral peroneus longus and brevis in the 1.5 m PAB group were higher than those in the 1.5 m control group, and the differences were significant ( t=5.28, 4.56, both P<0.001). The MVE% values of left tibialis anterior and left gastrocnemius in the 2 m PAB group were lower than those in the 2 m control group, and the differences were significant ( t=2.21, 0.53, 4.35, P=0.031, 0.598, <0.001). The MVE% values of bilateral peroneus longus and brevis in the 2 m PAB group were higher than those in the 2 m control group, and the differences were significant ( t=4.92, 6.31, both P<0.001). With the ankle protection the MVE% values of bilateral tibialis anterior, gastrocnemius, peroneus longus and brevis in the 1.5 m PAB group were lower than those in the 2 m PAB group, and the differences were significant ( t=3.56-4.94, all P≤0.001). The MVE% values of bilateral tibialis anterior, gastrocnemius, peroneus longus and brevis in the 1.5 m control group were lower than those in the 2 m PAB group, and the differences were significant ( t=2.30-5.85, all P<0.05). Conclusions:PAB can reduce the ankle injury during airborne force landing and provide good protection.

Objective:To provide an effective protection method for reducing the ankle injury during airborne force landing by investigating the protective effect of a protective ankle brace (PAB).Methods:Airborne soldiers were selected as subjects and they were asked to jump from 1.5 m and 2 m high training platform with and without PAB protection. They maintained a standard bending and knee-bending posture as they touched the buffer surface of the training ground. Each subject completed 4 simulated landing trials: from 1.5 m with PAB (1.5 m PAB group), from 2 m with PAB (2 m PAB group), from 1.5 m without PAB (1.5 m control group), and from 2 m without PAB (2 m control group). The muscle electrical signals of bilateral tibialis anterior, peroneal longus and brevis and gastrocnemius were recorded by surface electromyography, and the percentage of maximal voluntary electrical activation (MVE%) was calculated and analyzed.Results:Sixty-one subjects were included. At the same height with different ankle protection status, the MVE% values of bilateral tibialis anterior and gastrocnemius in the 1.5 m PAB group were lower than those in the 1.5 m control group, and the differences were significant ( t=2.45, 2.74, 2.35, P=0.017, 0.008, 0.022). The MVE% values of bilateral peroneus longus and brevis in the 1.5 m PAB group were higher than those in the 1.5 m control group, and the differences were significant ( t=5.28, 4.56, both P<0.001). The MVE% values of left tibialis anterior and left gastrocnemius in the 2 m PAB group were lower than those in the 2 m control group, and the differences were significant ( t=2.21, 0.53, 4.35, P=0.031, 0.598, <0.001). The MVE% values of bilateral peroneus longus and brevis in the 2 m PAB group were higher than those in the 2 m control group, and the differences were significant ( t=4.92, 6.31, both P<0.001). With the ankle protection the MVE% values of bilateral tibialis anterior, gastrocnemius, peroneus longus and brevis in the 1.5 m PAB group were lower than those in the 2 m PAB group, and the differences were significant ( t=3.56-4.94, all P≤0.001). The MVE% values of bilateral tibialis anterior, gastrocnemius, peroneus longus and brevis in the 1.5 m control group were lower than those in the 2 m PAB group, and the differences were significant ( t=2.30-5.85, all P<0.05). Conclusions:PAB can reduce the ankle injury during airborne force landing and provide good protection.

The autoimmune cardiomyopathy is a variety of myocardial diseases with significant individual heterogeneity that is mediated by autoimmunity reaction. However, the pathogenesis of the autoimmune cardiomyopathy has not been clearly known. Multiple autoantibodies have been detected in the sera of patients with autoimmune cardiomyopathy, and the studies of related autoantibody profile contributes to understanding the pathogenesis, improving screening and diagnosis, supervising disease progression, estimating prognosis and therapeutic effects. This review will summarize the progress and clinical application of the autoantibody profile in patients with autoimmune cardiomyopathy, providing a reference for clinical practice.

Objective To investigate the preparation method of hydroxyapatite by amino acids induced hydrothermal technique.Methods The hydroxyapatite nanorods were obtained using alanine and glycine as templates by hydrothermal method.The samples were characterized by X-ray diffraction (XRD),Fourier infrared spectroscopy (FTIR),transmission electron microscopy (TEM).Results The results showed that amino acids induced the formation of hydroxyapatite.Amino acids could affect crystallinity and dispersion of the formed hydroxyapatite.In addition,the substituent content of carbonate ions in hydroxyapatite was reduced by changing the ratio of amino acids.Conclusion Hydroxyapatite with high crystallinity and low carbonate ions can be prepared by hydrothermal method in the presence of amino acids.

Objective To investigate the clinical application of forearm arteriovenous fistula in uremia patients, and find out the cause of fistula dysfunction. Methods Three hundred and forty-five chronic uremia patients were collected. Forearm arteriovenous fistula were set up as vascular access. Recorded the relationship betwe the using condition. Results Chronic nephritis was the most, and diabetic nephropathy was lowest in the using fistula time exceeding 2 years, the internal fistula losing function occurred 103 cases in 1 year after intenal fistula establishment, the highest rate was diabetic nephropathy, then hypertension innocence renal arteriolar sclerosis. There were significant difference beween diabetic nephropathy, hypertension innocence renal arteriolar sclerosis and chronic nephritis (P<0.05). Conclusion In diabetic nephropathy and hypertension patients, the using time of fistula is short and the accidence of fistula dysfunction is high.